Yale Ventures

Meet the presenters! We are pleased to announce the 34 Yale faculty members selected to present at the?Yale Life Science Pitchfest on December 5. The event will showcase groundbreaking research in #therapeutics #medicaldevices #diagnostics and #digitalhealth. The annual event also serves as the semifinals for?The Blavatnik Fund for Innovation at Yale, an accelerator fund dedicated to advancing the commercialization of applied research and technology in the life sciences. Following the event, guests are invited to attend the?BioCT Annual Holiday Party?to network, connect with colleagues, and celebrate the?Entrepreneur of the Year. Meet the presenters: https://lnkd.in/gpHVdBQ4

Yale cardiologist Rohan Khera discusses how AI will ‘ultimately make health care better for everyone.’ Dr. Khera is a 2024 recipient of a Yale Faculty Innovation Award and a 2023 recipient of a Blavatnik Fund Award. Watch the segment: https://lnkd.in/ga3VKpQd

Have you registered for the Yale Life Sciences Pitchfest yet? The annual event will take place on December 5 showcasing?groundbreaking Yale University research in therapeutics, medical devices, and digital health. Registration is free for Yale.edu emails: https://bit.ly/3O5XW80

?? ?? Exciting news from the XPRIZE Rainforest competition! The Map of Life Rapid Assessments (MOLRA) team, led by Walter Jetz, professor of ecology and evolutionary biology and director of the?Yale Center for Biodiversity and Global Change, has placed 2nd in the global challenge to advance technology for exploring Earth’s biodiversity. The international team earned $2M for their groundbreaking efforts in biodiversity tracking. The announcement was made on Nov. 15 at the G20 Social Summit in Rio de Janeiro. Congratulations to the MOLRA team! Read the story: https://lnkd.in/ejNWV2pT

“Yale is an incredible place to cross scientific boundaries.”—John Krystal, MD, in conversation with Freedom Biosciences co-founder and CEO Dina Burkitbayeva. The event was part of the Innovation and Entrepreneurship Seminar series co-hosted with Yale Pathology. Dr. Krystal discussed his pioneering research with Dr. Robert Berman that first demonstrated ketamine’s rapid antidepressant effects and directly led to the FDA-approved Esketamine spray. The co-founders also discussed translational neuroscience and the path for bringing novel therapeutics to market, the importance of exploring drug interactions in psychiatry, and the current funding environment for biotech and life sciences ventures. Freedom Biosciences, a Yale University spinout co-founded by Dr. Krystal is creating the next generation of ketamine-based and neuropsychiatric pharmaceuticals to develop more viable and efficacious treatment alternatives for millions of people currently suffering from debilitating mental health disorders. #Yale #YaleVentures #MentalHealth #Neuroscience #Biotech

Yale School of Engineering & Applied Science and Yale Ventures have launched the inaugural Yale Engineering Innovation Fellows program to equip advanced doctoral and postdoctoral researchers at Yale University with the skills to bring groundbreaking technologies to market. Meet the fellows: https://bit.ly/48ZQiFV

Congratulations to the entire Tsai Center for Innovative Thinking at Yale (Tsai CITY) team!

Congratulations to Craig Crews on being named a Top 50 BioTech Entrepreneur of 2024 by Great Entrepreneurs. A serial academic entrepreneur, Dr. Crews has a foothold in both the academic and biotech arenas; on the faculty at Yale University since 1995, his laboratory has pioneered the use of small molecules to control intracellular protein levels. He is also the founder of several #biotech companies including the New Haven-based biotech Arvinas.? https://lnkd.in/gYvy9J6w

Ever wondered how a Yale grad went from crunching code to reshaping the venture capital landscape? Discover how Gabby Cazeau (SOM '20) transitioned from engineering to venture capital, gaining insights on innovation at General Mills and Microsoft before making an impact in startups and investments. Recognizing the importance of diversity in entrepreneurship, Gabby's mission in venture capital addressed funding imbalances. Her goal: "invest in a thousand diverse founders over the next 20 years." She notes "Women and minority-owned startups only receive under 3% of venture funding...representing 70% of the US population." Gabby returned to Yale to speak with Joe Tsai, BA '86,?JD?'90, and offer advice to current students. Whether you're an intrapreneur, joiner, or founder, this video is packed with inspiration and actionable tips for you! Link here: https://lnkd.in/err279iQ #Innovation #DiversityInTech #Entrepreneurship #Yale #VentureCapital #StartupAdvice

Stephen Knight, president and managing partner of the healthcare and technology venture capital firm F-Prime Capital, joins the latest episode of Health & Veritas podcast to discuss his career in #biotech #investing. He holds an MD from Yale School of Medicine, an MBA from Yale School of Management, and serves on the Yale Ventures Board of Advisors. Listen: https://lnkd.in/eQzStASz